Just under £15 now, GSK’s share price looks cheap to me anywhere below £48.13
GSK’s (LSE: GSK) share price has gained 20% from its 9 April one-year traded low of £12.42. One reason is the lack of extra US tariffs placed on UK pharmaceutical companies, as had been mooted. That said, this does remain a risk for the firm.
Another reason is the reduction in litigation risk surrounding its Zantac product, although again a risk remains. This followed the October 2024 $2.2bn (£1.63bn) settlement by GSK that resolved 93% of lawsuits related to the drug.
And I think the final reason has been very strong results from the company since its one-year low. These are forecast to continue to the end of 2027 at minimum.
I believe these will drive the firm’s share price much…
